127 related articles for article (PubMed ID: 38312062)
41. Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.
Haghighatafshar M; Ghaedian M; Etemadi Z; Entezarmahdi SM; Ghaedian T
Nucl Med Commun; 2018 May; 39(5):430-434. PubMed ID: 29517578
[TBL] [Abstract][Full Text] [Related]
42. A kinetic compartment model for evaluating salivary gland scintigraphies.
Afzelius P; Fuglsang S
Clin Physiol Funct Imaging; 2014 Mar; 34(2):143-50. PubMed ID: 23909953
[TBL] [Abstract][Full Text] [Related]
43. Computed tomography features of the major salivary glands after radioactive iodine ablation in patients with papillary thyroid carcinoma.
Kim DW
Radiol Med; 2018 Jan; 123(1):20-27. PubMed ID: 28932970
[TBL] [Abstract][Full Text] [Related]
44. Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma.
Soo Roh S; Wook Kim D; Jin Baek H
AJR Am J Roentgenol; 2016 Nov; 207(5):1077-1081. PubMed ID: 27504709
[TBL] [Abstract][Full Text] [Related]
45. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
46. Early Quantification of Salivary Gland Function after Radioiodine Therapy.
Tanwar KS; Rana N; Mittal BR; Bhattacharya A
Indian J Nucl Med; 2021; 36(1):25-31. PubMed ID: 34040292
[TBL] [Abstract][Full Text] [Related]
47. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
[TBL] [Abstract][Full Text] [Related]
48. The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.
Haghighatafshar M; Nowshad R; Etemadi Z; Ghaedian T
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):321-325. PubMed ID: 29696945
[TBL] [Abstract][Full Text] [Related]
49. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.
Bohuslavizki KH; Klutmann S; Jenicke L; Kröger S; Buchert R; Mester J; Clausen M
Cancer Biother Radiopharm; 1999 Oct; 14(5):337-47. PubMed ID: 10850318
[TBL] [Abstract][Full Text] [Related]
50. Salivary gland protection with sialagogues: a case study.
Van Nostrand D; Atkins F; Bandaru VV; Chennupati SP; Moreau S; Burman K; Wartofsky L
Thyroid; 2009 Sep; 19(9):1005-8. PubMed ID: 19500022
[TBL] [Abstract][Full Text] [Related]
51. Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation.
Krčálová E; Horáček J; Gabalec F; Žák P; Doležal J
Eur J Oral Sci; 2020 Jun; 128(3):204-210. PubMed ID: 32239618
[TBL] [Abstract][Full Text] [Related]
52. Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients: analysis of quantitative salivary scan.
Kim SJ; Choi HY; Kim IJ; Kim YK; Jun S; Nam HY; Kim JS
Thyroid; 2008 Mar; 18(3):325-31. PubMed ID: 18341378
[TBL] [Abstract][Full Text] [Related]
53. Optimal administration time of vitamin C after
Liu Y; Wang Y; Zhang W
Front Surg; 2022; 9():993712. PubMed ID: 36211303
[TBL] [Abstract][Full Text] [Related]
54. Semi-quantitative evaluation of salivary gland function in Sjögren's syndrome using salivary gland scintigraphy.
Zou Q; Jiao J; Zou MH; Xu JH; Pan YF; Chen JN; Cheng MH; Zhang F; Zhang Y
Clin Rheumatol; 2012 Dec; 31(12):1699-705. PubMed ID: 22941258
[TBL] [Abstract][Full Text] [Related]
55. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
[TBL] [Abstract][Full Text] [Related]
56. Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET.
Hobbs RF; Jentzen W; Bockisch A; Sgouros G
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):79-91. PubMed ID: 23474639
[TBL] [Abstract][Full Text] [Related]
57. Single-photon emission computed tomography/computed tomography for evaluation of salivary gland dysfunction: preliminary study on diagnostic ability of maximum standardized uptake value.
Ninomiya K; Toya S; Ogura I
Oral Radiol; 2020 Apr; 36(2):163-167. PubMed ID: 31201645
[TBL] [Abstract][Full Text] [Related]
58. Quantitative and visual evaluation of salivary and thyroid glands in patients with primary Sjögren's syndrome using salivary gland scintigraphy: relationship with clinicopathological features of salivary, lacrimal and thyroid glands.
Güne S; Yilmaz S; Karalezli A; Aktaş A
Nucl Med Commun; 2010 Jul; 31(7):666-72. PubMed ID: 20545046
[TBL] [Abstract][Full Text] [Related]
59. Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren's syndrome.
Aksoy T; Kiratli PO; Erbas B
Clin Rheumatol; 2012 Sep; 31(9):1365-70. PubMed ID: 22733368
[TBL] [Abstract][Full Text] [Related]
60. Salivary gland function in women with Hashimoto's thyroiditis without xerostomia and the correlation with auto-thyroid antibodies.
Pang XA; Wei ZX; Li JH; Pang XQ
Nuklearmedizin; 2021 Feb; 60(1):47-54. PubMed ID: 33124031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
